03:39 PM EST - QLT Inc. : Announced today completion of enrollment in its retrospective, uncontrolled, multi-centre Natural History Study in subjects with Inherited Retinal Disease phenotypically diagnosed with Retinitis Pigmentosa or Leber Congenital Amaurosis due to underlying Retinal Pigment Epithelial 65 protein or Lecithin:Retinol Acyltransferase gene mutations. QLT Inc.
shares T.QLT are trading down $0.07 at $1.93.
